e-learning
resources
London 2016
Tuesday, 06.09.2016
From microimaging to functional evaluation of the lung
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Change in right atrial minimal volume is a prognostic marker in pulmonary arterial hypertension (PAH)
Euan Tubman (Sheffield, United Kingdom), Euan Tubman, Tom Sproson, Dave Capener, Robin Condliffe, Charlie Elliot, Athanasios Charalampopolous, David Kiely, Jim Wild, Andy Swift
Source:
International Congress 2016 – From microimaging to functional evaluation of the lung
Session:
From microimaging to functional evaluation of the lung
Session type:
Oral Presentation
Number:
3511
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Euan Tubman (Sheffield, United Kingdom), Euan Tubman, Tom Sproson, Dave Capener, Robin Condliffe, Charlie Elliot, Athanasios Charalampopolous, David Kiely, Jim Wild, Andy Swift. Change in right atrial minimal volume is a prognostic marker in pulmonary arterial hypertension (PAH). Eur Respir J 2016; 48: Suppl. 60, 3511
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Prognostic relevance of right atrial function in pulmonary arterial hypertension
Source: International Congress 2017 – Cardiac function assessment in pulmonary hypertension
Year: 2017
Prognostic value of changes in radionuclide right ventricular ejection fraction in pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013
Ratio of pulmonary arterial to aortic diameter and right to left ventricular diameter associate with poor outcome in medically-treated chronic thromboembolic pulmonary hypertension
Source: International Congress 2015 – A more functional view of chest pathology
Year: 2015
Right ventricular and pulmonary vascular interaction in pulmonary arterial hypertension
Source: Annual Congress 2008 - Pulmonary hypertension in connective tissue diseases
Year: 2008
Pulmonary vascular gradient: A predictor of prognosis in pulmonary hypertension due to left heart disease
Source: Annual Congress 2012 - Pulmonary circulation: end-points and biomarkers
Year: 2012
Right ventricular systolic pressure as a prognostic factor for pulmonary hypertension with interstitial lung disease
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019
Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease
Source: Eur Respir Rev 2011; 20: 236-242
Year: 2011
Prognostic value of systolic pulmonary artery pressure change at exercise in pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: management
Year: 2015
Vascular and right ventricular remodelling in chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2013; 41: 224-232
Year: 2013
Changes in right ventricular mass are unrelated to changes in pulmonary pressures in pulmonary arterial hypertension
Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension
Year: 2011
The role of the right ventricle in pulmonary arterial hypertension
Source: Eur Respir Rev 2011; 20: 243-253
Year: 2011
Impaired right ventricular diastolic function in systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension
Source: Annual Congress 2008 - Pulmonary vascular medicine
Year: 2008
Association of renal dysfunction with cardiac output and right atrial pressure in pulmonary arterial hypertension
Source: Annual Congress 2011 - Physiology of human pulmonary hypertension
Year: 2011
Mobile spiroergometry for prediction of survival in pulmonary arterial hypertension (PAH)
Source: Annual Congress 2009 - Pulmonary vascular diseases
Year: 2009
Left atrial volume to distinguish idiopathic pulmonary arterial hypertension from pulmonary hypertension due to left heart disease
Source: Annual Congress 2011 - Clinical features of human pulmonary hypertension
Year: 2011
Load-independent right ventricular function and idiopathic pulmonary arterial hypertension severity
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013
The association between resting and mild-to-moderate exercise pulmonary artery pressure
Source: Eur Respir J 2012; 39: 313-318
Year: 2012
Measurement of cardiac troponin identifies patients with moderate to large pulmonary emboli and right ventricular strain
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014
The right ventricle (RV) in systemic sclerosis-associated pulmonary arterial hypertension (SSCPH)
vs
idiopathic pulmonary arterial hypertension (IPH): higher inflammatory status, no increase in interstitial fibrosis
Source: Annual Congress 2009 - Pulmonary vascular diseases
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept